Skip to content

RISE for Nurse Preceptors

A Randomized Controlled Trial of RISE for Nurse Preceptors

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06822777
Enrollment
124
Registered
2025-02-12
Start date
2025-03-01
Completion date
2026-02-28
Last updated
2025-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burnout, Healthcare Workers, Empowerment, Mental Health, Resilience, Self-Compassion, Well-Being, Psychological

Brief summary

The purpose of this study is to determine whether RISE for Nurse Preceptors has a significant impact on nurse preceptors' burnout, resilience, insight, self-compassion, and empowerment, as well as mental well-being, in their personal lives and their working environment.

Interventions

BEHAVIORALRISE for Nurse Preceptors Program

Psychoeducational group program designed to impact resilience, insight, self-compassion, and empowerment

Sponsors

AdventHealth
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Adult ≥ 18 years old 2. Licensed as an RN 3. Employed by AdventHealth Rocky Mountain Region 4. Completion of the AdventHealth preceptor training 5. Has precepted ≥ 48 hours within the past calendar year in an AdventHealth hospital setting or outpatient emergency center 6. Able to speak, read, and understand English fluently 7. Able to provide informed consent 8. Willing and able to comply with all study procedures and requirements for the duration of the study.

Exclusion criteria

1. Has precepted \< 48 hours within the past calendar year 2. Does not pass the brief risk assessment in the pre-intervention introduction meeting with the LMHC facilitator 3. Unwilling or unable to comply with all study procedures and requirements for the duration of the study.

Design outcomes

Primary

MeasureTime frameDescription
Professional Quality of Life ScaleBaseline, endpoint, and 1-, 3-, and 6-month follow-up30-item questionnaire with the following response categories: 1=never, 2=rarely, 3=sometimes, 4=often, 5=very often

Secondary

MeasureTime frameDescription
Generalized Anxiety Disorder - 2 item scaleBaseline, endpoint, and 1-, 3-, and 6-month follow-up2-item questionnaire with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day
Posttraumatic Growth InventoryBaseline, endpoint, and 1-, 3-, and 6-month follow-up21-item questionnaire with a scale of 0-5, with 0 meaning I did not experience this change as a result of my crisis; and 5 meaning I experienced this change to a very great degree as a result of my crisis
Brief Resilience ScaleBaseline, endpoint, and 1-, 3-, and 6-month follow-up6-item questionnaire with the following response categories: 1=strongly agree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree
Self-Reflection and Insight ScaleBaseline, endpoint, and 1-, 3-, and 6-month follow-up20-item questionnaire with a scale of 1-6; with 1 meaning strongly disagree; and 6 meaning strongly agree
Self-Compassion Scale - Short FormBaseline, endpoint, and 1-, 3-, and 6-month follow-up12-item questionnaire with the following response categories: 1=almost never, 2, 3, 4, 5=almost always
Brief COPEBaseline, endpoint, and 1-, 3-, and 6-month follow-up28-item questionnaire with a scale of 1-4, with 1 meaning I haven't been doing this at all; and 4 meaning I've been doing this a lot
General Self-Efficacy ScaleBaseline, endpoint, and 1-, 3-, and 6-month follow-up10-item questionnaire with the following response categories: 1=not at all true, 2=barely true, 3=moderately true, 4=exactly true
Perceived Stress ScaleBaseline, endpoint, and 1-, 3-, and 6-month follow-up10-item questionnaire with the following response categories: 0=never, 1=almost never, 2=sometimes, 3=fairly often, 4=very often
Moral Injury Outcomes ScaleBaseline, endpoint, and 1-, 3-, and 6-month follow-up14-item questionnaire with the following response categories: 0=strongly agree, 1=disagree, 2=neither agree or disagree, 3=agree, 4=strongly agree
Patient Health Questionnaire - 2 itemBaseline, endpoint, and 1-, 3-, and 6-month follow-up2-item scale with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day
Preceptor Self-Assessment ToolBaseline, endpoint, and 1-, 3-, and 6-month follow-up40-item scale with the following response categories: 1 (lowest), 2 (low), 3 (average), 4 (high), 5 (highest).
Psychological Empowerment InstrumentBaseline, endpoint, and 1-, 3-, and 6-month follow-up12-item questionnaire with a scale of A-G, with A meaning very strongly disagree; and G meaning very strongly agree

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026